Evaluation of Chemotherapy- induced Adverse Events in Breast Cancer Patients receiving Chinese Herbal Medicine Treatment in Hospital Kepala Batas, Malaysia.
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: LIEW, Ai Ch'i (Universiti Sains Malaysia, Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Penang, Malaysia)
- Co-author(s): Peh, Kok Khiang (Universiti Sains Malaysia, Penang, Malaysia)
Zhao, Wei (Guang'anmen Hospital, Beijing, China)
Tan, Boon Seang (Penang General Hospital, Penang, Malaysia)
Tangiisuran, Balamurugan (Universiti Sains Malaysia, Penang, Malaysia)
Chinese herbal medicine (CHM) is a complementary therapy often used in reducing chemotherapy-induced adverse events (AE) albeit with a paucity of evidence in its clinical effectiveness.
This study aims to evaluate the effectiveness of CHM in reducing chemotherapy-induced AE and improving Health Related Quality of Life (HRQoL) in .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.